Earnings Feed
Start Free
Home/Filings/4/0001209191-18-062126
4//SEC Filing

Owens Julia C. 4

Accession 0001209191-18-062126

CIK 0001544227other
View on SEC.govCompany Profile

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 7:49 PM ET

Size

12.7 KB

Accession

0001209191-18-062126

Insider Transaction Report

Form 4
Period: 2018-12-07
Millendo Therapeutics, Inc.MLND
Owens Julia C.
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-12-07+151,600→ 151,600 total
    Exercise: $4.44Exp: 2026-01-27→ Common Stock (151,600 underlying)
  • Award

    Employee Stock Option (right to buy)

    2018-12-07+60,179→ 60,179 total
    Exercise: $1.08Exp: 2022-08-29→ Common Stock (60,179 underlying)
  • Award

    Employee Stock Option (right to buy)

    2018-12-07+174,839→ 174,839 total
    Exercise: $16.40Exp: 2028-08-23→ Common Stock (174,839 underlying)
  • Award

    Common Stock

    2018-12-07+74,400→ 74,400 total
Footnotes (7)
  • [F1]Received in exchange for 1,000,000 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger").
  • [F2]Fully vested.
  • [F3]Received in connection with the Merger in exchange for a stock option to acquire 808,867 shares of Millendo common stock for $0.08 per share.
  • [F4]Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
  • [F5]Received in connection with the Merger in exchange for a stock option to acquire 2,037,648 shares of Millendo common stock for $0.33 per share.
  • [F6]Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
  • [F7]Received in connection with the Merger in exchange for a stock option to acquire 2,350,000 shares of Millendo common stock for $1.22 per share.

Documents

1 file

Issuer

Millendo Therapeutics, Inc.

CIK 0001544227

→
Entity typeother

Related Parties

1
  • filerCIK 0001760219

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 7:49 PM ET
Size
12.7 KB
View on SEC.gov